chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The patient started to experience an itchy throat 45 min after injection. Has a history of allergic reactions to augmentin. Benadryl was given and the patient waited 10 min for monitoring and then went home.
At around 11:45, my son developed a fever of 100.4, and a general feeling of sickness. He took Advil and didn?t really feel a lot better. He could not do his usual activities. At around 6pm, he started feeling worse, so I gave him Tylenol. The next morning, Sunday, 11/5/2017, he felt much better. However, on 11/7/2017 he developed cold like symptoms (maybe not related to the vaccine ?). Today, 11/8/2017, he was sent home from school due to coughing.
This spontaneous report was received from a physician via a company representative and refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 16-JUN-2015, the patient was vaccinated with a dose of improperly stored VAQTA (10Pk 50U/1 mL) lot number K008984, expiration date of 21-OCT-2015 (route of administration was not reported), which was stored 3 times with the following lowest recorded temperatures: 34F (1.11 Celsius degrees) for 88 hours, 32 F (0 Celsius degrees) for 40 hours and 33 F (0.555 Celsius degrees) for 40 hours. No highest reported temperatures were reported. The type of storage was refrigerator. No concomitant therapies were reported. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several cases from the same reporter. Additional information has been requested.
On 30 Aug 2007, patient received Menactra and Tdap,October 22, 2007 patient had a tonic/clonic seizure with aura prior. She never had a seizure prior to this episode. CT Scan and EEG were normal afterwards. No seizure since.  11/16/07 Reviewed hospital medical records which reveal patient experienced HA, flash/dream events x 1 day, confusion.  Fell in shower & found w/eyes rolled back & legs shaking x 8-9 min followed by lethargy & sleepiness.  EMS found patient postictal.  Admitted 10/23-24/2007 for observation.  Exam revealed TMs dull w/effusion, enlarged tonsils,  maxillary sinus tenderness.  Consulted w/peds neuro.  Tx w/IV antibiotics.  FINAL DX: Transient LOC, seizure by history.
About a week after injection experienced constant dizziness as well as intermittent vertigo episodes.  Sought out physical therapy for epley maneuver 1/19/21.  Had to attend multiple PT appointments for this as dizziness did not go away.  Saw an ENT on 2/26/21 who could not determine cause other then BPPV.  Continued PT and continue to have intermittent dizziness now (3/31/21)
MMR rash, spread from face to abdomen, down back, legs, etc.  Then developed hives on 12/30/10 (wheal and flare type reaction). Today is day 3 of hives, MMR rash on face still but has improved everywhere else.
Patient received flu vaccine 11/16/05. Later that evening became dizzy, felt "fluttering" sensation in right breast and fainted. Also felt "itchy." S/S continued next day, though decreased and with no fainting. Urged pt to go to Urgent Care.
Fainted; Mental confusion; Now have an outbreak of Erythemia Multiformae, a secondary condition related to Herpes.; Now have an outbreak of Erythemia Multiformae, a secondary condition related to Herpes.; This is a spontaneous report from a contactable consumer (patient). A 37-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiration date: not reported), via an unspecified route of administration, in Left Arm, on 13Sep2021 at 19:45 (at the age of  37-year-old) as DOSE 2, SINGLE for covid-19 immunization.  Medical history included, Herpes Simplex Outbreaks occasionally, Erythema Multiforme. Concomitant medication included Medical Cannabis. The patient was allergic to Tetracycline & erythromycin. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date: not reported), on Aug2021 (at the age of 37-year-old) as DOSE 1, SINGLE for covid-19 immunization and experienced Herpes Outbreak. The patient was not pregnant at time of vaccination. The patient didn't receive any other vaccines within 4 weeks prior to the COVID -19 vaccine. The Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. On 13Sep2021, After the second vaccine, patient fainted within 2 minutes of receiving the shot & have had mental confusion ever since. On Sep2021, 1 week after the second shot, patient now have an outbreak of Erythemia Multiformae, a secondary condition related to Herpes. The outcome of the events was unknown at time of report.  The lot number for BNT162B2, was not provided and will be requested during follow up
Chills, weakness, light headed, slight nausea ,  slight arm pain at injection sight. Only treatment was go to bed
Afternoon next day had headache, dizziness, tingling and numbness on extremities, 101 fever, muscle aches, totally lethargic (felt like if walked into a door), rapid heart beat, double vision like when cross eyed. Given ibuprofen for fever. In the morning took another ibuprofen got dizzy in school and just wanted to sleep. It is very out of the norm since she usually rune 3-4 miles a day. Had fever of 100.7. Symptoms continued, felt like if heart beat was even faster. On Saturday had 103.7 fever so taken to the ER. Blood work revealed low WBC and platelets. Felt extremely hot and sweaty and then really cold. Face was beet red, even the whites of her eyes were red. Sent home from ER. Sunday was feeling better. Today, low grade fever but dropping from prior readings. She went to school but picked up by 10am and taken to the doctor for fever, reading around 102.7. Strep throat test done and negative. No other flu like symptoms. Continue to take fever reducing medicine (TYLENOL and ibuprofen). Temp is dropping but she still looks out of it, has a glazed look.
He got his vaccine, he was light headed for about an hour (typical for him for vaccines).  The next day he was somewhat tired and his arm was sore for 3 days (not any more).  He has a colostomy and had trouble passing stool.  He got his first vaccine on 11/2/21 and had loose stools all day, which this was different.  When he did pass the stool the edge of the stoma bled quite a bit when passing due to it being so hard.   The bleeding stopped, but felt it was due to the Plavix.  He is still having constipation issues now, 4 days.  It's very rare for him to bleed during him having a stool, and feels that it should be reported.
(Mother) stated that patient had a severe headache suddenly about a half hour after getting vaccinations. She describes the headache as severe and said that patient told her his head is pounding and was holding his head. Mother took him to the ER where they treated him for a migraine. On morning of 08/02/2017 mother states patient is feeling better.
Could not pick her arm up over her head until day 3; Bad headache along the level of a migraine; Every muscle was hurting; Headache was intense and painful; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (Could not pick her arm up over her head until day 3), MIGRAINE (Bad headache along the level of a migraine), MYALGIA (Every muscle was hurting) and HEADACHE (Headache was intense and painful) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 071B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced MIGRAINE (Bad headache along the level of a migraine), MYALGIA (Every muscle was hurting) and HEADACHE (Headache was intense and painful). On 02-Apr-2021, the patient experienced MOBILITY DECREASED (Could not pick her arm up over her head until day 3). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, MOBILITY DECREASED (Could not pick her arm up over her head until day 3), MIGRAINE (Bad headache along the level of a migraine) and MYALGIA (Every muscle was hurting) outcome was unknown and HEADACHE (Headache was intense and painful) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitants were not provided. Treatment was not provided.
Got the vaccine in the morning, had a seizure, nausea, chills at night.
my neck was itchy; hives on my left forearm; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 26 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 13Mar2021 20:00 (Lot number: EN6205) at the age of 25 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Strawberries, reaction(s): "Allergy"; Ciprofloxacin, reaction(s): "Allergy"; Gadolinium, reaction(s): "Allergy". Vaccination history included: Bnt162b2 (COVID 19, brand=Pfizer, lot number=EN6198, administration date=20Feb2022, administration time=08:00 PM, dose number=1 vaccine location=Left arm), administration date: 20Feb2021, for COVID-19 immunization. The following information was reported: PRURITUS (non-serious), outcome "recovering", described as "my neck was itchy"; URTICARIA (non-serious), outcome "recovering", described as "hives on my left forearm". Therapeutic measures were not taken as a result of pruritus, urticaria.  Additional Information: It was reported that, after getting the second dose of pfizer, I immediately started to get hives on my left forearm and my neck was itchy. My left arm also broke out in pimples for about 3 months.  No follow-up attempts are possible. No further information is expected.
Large Red elongated area about the size of  a  stretched tennis ball  on  left arm around injection site - hot to the touch - iced off/on for 2days and subsided in temperature  and size. Could not report on v-safe because my phone will not accept  verification code by test for some reason and app did not allow verification by email unfortunately.
One to two weeks after the injection developed a rash. Denies fever, swollen lymph nodes. Rash, burns & itches. Skin turning dark. Has not resolved in 2 months.
pt recvd vax in 1985 & exp a viral like reaction that lasted for 3 days;
pt recvd vax; inject site red, swollen, tender, v x 1; h/a & inc tl sxs started 6 hrs after vax;
This spontaneous report was received from a registered nurse and refers to an unspecified adult patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On an unknown date, the patient was vaccinated with two pediatric doses of VAQTA 25/0.5 for prophylaxis (route of administration, anatomical location, lot# and expiration date were not reported). No adverse event was reported. Product quality complaint was not reported. Additional information has been requested.
HPV injection approximately 10:30 am 7/20. 9 pm 7/20 fever, and chills; called and spoke with on-call MD, advised ibuprofen 400 mg every 608 hrs. Had intermittent HA, otherwise no localized pain. No rashes. Continue ibuprofen every 6-8 hrs.
Chills, sweats, headache, fatigue, loss of appetite, body aches.
Information has been received from a registered nurse concerning a 5 year old male, with a history of asthma and many unknown allergies, who on 26-AUG-2004 was vaccinated with a first dose of Recombivax HB. It was reported that in his third year of his life, approximately 2005, it was discovered that "he was not making antibodies". The patient was seen by allergists, pulmonologists and endocrinologist, and many unknown tests were performed. During 2006 the patient was hospitalized four times. The patient received a second dose of Recombivax on 30 APR 2007. The reporter considered the adverse event "not making antibodies" to be Disabling, Life Threatening, and required hospitalization. At the time of reporting the patient was recovered. Lot numbers were not provided. There was no product quality complaint. Additional information has been received from a registered nurse, who adamantly stated this was not a report of an adverse event with Recombivax, it was strictly a question to inquire about the dosing schedule and whether the extended period between vaccines would change the vaccines effectiveness. The patient was vaccinated on 26-AUG-2004 then again 30-APR-2007 and the final vaccination was on 22-AUG-2007 (LOT # 655565/0007U. The nurse reported that this is a sickly patient with asthma who has a long medical history none of which had anything to do with this vaccine (Lot # 655565/0007U, Batch #0007U).
bumps/blisters at the tip of her tongue; painful bumps/blisters at tip of her tongue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of TONGUE BLISTERING (bumps/blisters at the tip of her tongue) and GLOSSODYNIA (painful bumps/blisters at tip of her tongue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TONGUE BLISTERING (bumps/blisters at the tip of her tongue) and GLOSSODYNIA (painful bumps/blisters at tip of her tongue). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) for Adverse event, at a dose of UNK dosage form. At the time of the report, TONGUE BLISTERING (bumps/blisters at the tip of her tongue) and GLOSSODYNIA (painful bumps/blisters at tip of her tongue) outcome was unknown. Not Provided
Head, body aches and fever on day 1-2, then itchy red rash on back
In addition to fever the day after, headaches several days, then a cough, all of the sudden in October (22nd or so) I started feeling something odd in my chest/throat. Not pain, but similar to a fast heartrate and/or difficulty breathing.  Similar to anxiety in stressful situation, but that is rare with me.  I finally checked my blood pressure, although mine has ALWAYS been lOw.  It showed elevated.  I haven't went to the doctor yet, hoping it would stop, but I'm going to have to make an appointment because something isn't right.
Headache, chills, myalgia, fever >102, fatigue, rash. Patient went to ED on 6/2/16 and 6/4/16. WBC > 20,000. Discharged on PO prednisone.
Pt developed urticaria on back, chest, arms, and face that wax and wane throughout the day.  Symptoms started 26DEC and worsened over 3 days to include stridor. Pt presented to the ER for evaluation and was given IV antihistamines and steroids. Discharged from ER with 6 day steroid burst, pepcid, and loratadine. Symptoms failed to improve and pt has now been started on maximal antihistamine therapy.
FEELING LOUSY; LOSS OF APPETITE; Cold; Flu like symptoms; Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (FEELING LOUSY), DECREASED APPETITE (LOSS OF APPETITE), INFLUENZA LIKE ILLNESS (Flu like symptoms), NASOPHARYNGITIS (Cold) and DIARRHOEA (Diarrhea) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. In October 2021, the patient experienced DIARRHOEA (Diarrhea). On 19-Nov-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms). On an unknown date, the patient experienced FEELING ABNORMAL (FEELING LOUSY), DECREASED APPETITE (LOSS OF APPETITE) and NASOPHARYNGITIS (Cold). At the time of the report, FEELING ABNORMAL (FEELING LOUSY) outcome was unknown and DECREASED APPETITE (LOSS OF APPETITE), INFLUENZA LIKE ILLNESS (Flu like symptoms), NASOPHARYNGITIS (Cold) and DIARRHOEA (Diarrhea) had not resolved.            Concomitant product use was not provided by the reporter. The patient received booster dose of Moderna vaccine. On unknown dates, the patient experienced feeling lousy, loss of appetite and cold. In October-2021, the patient experienced diarrhea. On 19-Nov-2021, the patient experienced flu like symptoms.  No treatment information was provided. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.      Reporter did not allow further contact
PATIENT WAS GIVEN A DOSE IN THIS PHARMACY AS HE TOLD US HE HAS NOT GOTTEN THE COVID SHOT YET. HE CAME BACK AFTER ONE DAY AND SHOWED A VACCINATION CARD WITH 2 PREV DOSES AT CVS FROM JAN AND FEB 2021
CDC contacted and stated that there should be no adverse effects, but these vaccines do not count and 6 weeks should lapse prior to any other vaccines being administered.
swelling; red spot; itching; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swelling), RASH MACULAR (red spot) and PRURITUS (itching) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03610BA) for COVID-19 vaccination.     No Medical History information was reported.    On 05-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, the patient experienced SWELLING (swelling), RASH MACULAR (red spot) and PRURITUS (itching). The patient was treated with HYDROCORTISONE ongoing since an unknown date at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at an unspecified dose and frequency. On 07-May-2021, SWELLING (swelling) and RASH MACULAR (red spot) had resolved. At the time of the report, PRURITUS (itching) had not resolved. Not provided.          Patient called to report adverse reaction. Moderna COVID-19 vaccine administered on 5May2021, after which patient reports that their arm started itching, became swollen and had a big red spot for 2 days after. Patient states that arm continues to be itchy at time of call, redness and swelling resolved. Patient is wondering if they should receive booster vaccine in alternate arm. Second dose information: 006C21A, expiration date unknown, administered on 5May2021 in left arm.
18 hours after vaccination, developed headache with severe nausea and intermittent vomiting and fever of between 99.5-101 when read via forehead.  Symptoms lasted for approximately 10 hours, with 1-3 bouts of vomiting during that time.  Due to vomiting, OTC pain relievers taken by mouth were not effective.  Symptoms have since subsided except for weakness, slight headache, and mental fog.
No other AE occurred; a dose of PROQUAD was expired and administered; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies, concurrent condition and concomitant medication were not provided.  On 22-MAR-2022, the patient was vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin (rHA)) (PROQUAD) (lot # t032150, expiration date reported as 20-MAR-2022; strength and route of administration were not reported) for prophylaxis (expired product administered). The reporter confirmed that no other adverse event (AE) occurred.
This case was reported by a consumer via other manufacturer and described the occurrence of light-headed feeling in a female patient who received SHINGRIX for prophylaxis. On 4th April 2018, the patient received SHINGRIX. On 5th April 2018, 1 days after receiving SHINGRIX, the patient experienced light-headed feeling and low blood pressure. The patient was treated with intravenous fluid (nos) (Intravenous Fluid). On an unknown date, the outcome of the light-headed feeling and low blood pressure were unknown. The reporter considered the light-headed feeling and low blood pressure to be related to SHINGRIX. Additional information was reported as follows: This case was received via Merck National Service Center. On 4th April 2018, the patient was vaccinated with a unspecified dose of SHINGRIX.  The batch number and expiry date of vaccine were unknown. On 5th April 2018, the patient felt light headed, and her blood pressure was measured to be very low. The patient reported calling her healthcare provider, who told her to eat chicken broth. The patient still felt light headed and called an ambulance. The patient received intravenous fluids and her healtcare care provider stated that it was a reaction to the vaccine. No further information was provided.
area at injection site showing a 1 1/2"  lesion(aka covid arm) going on 10 days, minor itchiness, feels firm and inflamed.
Vaccine was expired for 8 days. Given inadvertently due to confusion in extended dates. Vaccine stored in refrigerator and not ultra-cold. Used ultra-cold extended date instead of 10 week expiration date.
Nausea, vomiting, diarrhea x 2 days Headache and body ache x 2 more days   uticaria rash that still persists
Patient received second Moderna vaccine. Was nervous, started shaking shortly after, than reported her arm started getting numb, and was having trouble lifting her arm. Her heart rate and BP was fine, no dizziness, SOB either. Told patient to go to walk in clinic/ urgent care for review
I started to feel that my cognition brain function was not as sharp as it was before. I didn't know if that was part of the vaccination or part of another disease state that happens when people get vaccinations. I communicated it to the prescriber and it was documented as a known event after the vaccine. I am still experiencing the lessened brain function. I saw Doctor the neurologist. He is a neurologist at medical clinic. Non steroidal anti inflammatory- NSAID drug is what I have been prescribed.
Arm is swollen; Pain; This is a spontaneous report from a contactable consumer (patient's wife). A male patient of an unspecified age received bnt162b2 (BNT162B2 reported as COVID SHOT; unknown lot number and expiration date) at unknown age of vaccination via an unspecified route of administration in the arm on an unspecified date at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The wife reported that her husband who had a COVID shot Friday in his arm. The patient's arm was swollen and he was having pain. She inquired what can he do for that. The outcome of the event was unknown.   Information on the Lot/Batch number has been requested.
8FEB95 MN t105 lasted 2 hr, use APAP, cool wash cloths-down T103 2 hr later; went to MD-very lethargic; MD following day t101;
Feeling of warmth near injection site, pain, swelling and tenderness towards the elbow and pain around the neck.
A non-serious spontaneous report of administration of Influenza A (H1N1) to a 62-year-old female was received from a consumer. Neither relevant medical history nor concomitant medications have been reported for this patient. There was no adverse event associated with this vaccination error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the events are considered resolved.
Febrile illness t max 103. Severe myalgias. Redness at site.